Oxford Textbook of Rheumatoid Arthritis

1. History, diagnosis, and epidemiology 1: David L. Scott: The history of rheumatoid arthritis 2: Daniel Aletaha and Helga Radner: Diagnosis 3: James Gwinnutt and Deborah Symmons: The descriptive epidemiology of rheumatoid arthritis 4: Lars Klareskog and Lars Alfredsson: Modifiable and other risk factors for rheumatoid arthritis: a basis for prevention and better therapy 2. Pathogenesis 5: Anne Barton: Genetics and epigenetics of rheumatoid arthritis 6: Thomas Crowley, Jason Turner, Andrew Filer, Andy Clark, and Chris Buckley: Dysregulation of synovial fibroblasts in rheumatoid arthritis 7: Tom W. J. Huizinga: Autoantibodies in rheumatoid arthritis 8: Soi-Cheng Law, Pascale Wehr, Harriet Purvis, and Ranjeny Thomas: Dendritic cells and T cells in rheumatoid arthritis 9: Ukrike Steffen and Georg Schett: Mechanisms of bone and cartilage destruction 10: Marina Frleta-Gilchrist and Iain B. McInnes: Cytokines and other mediators 3. Clinical presentation 11: Annette van der Helm-van Mil: Clinical features of rheumatoid arthritis 12: Karim Raza, Catherine McGrath, Laurette van Boheemen, and Dirkjan van Schaardenburg: Pre-rheumatoid arthritis 13: Katherine MacDonald, Jennifer Hannah, and James Galloway: Non-articular manifestations of rheumatoid arthritis 14: Kimme Hyrich and Sarah Skeoch: Comorbidity in rheumatoid arthritis 4. Disease assessment 15: Josef Smolen: Disease activity assessment in rheumatoid arthritis 16: Douglas Veale and Ursula Fearon: Synovial biopsies 17: Charles Peterfy, Philip Conaghan, and Mikkel Ostergaard: Radiography in rheumatoid arthritis 18: Andrew Filer, Maria Antonietta D'Agostino, and Ilfita Sahbudin: Ultrasound in rheumatoid arthritis 19: Charles Peterfy, Philip Conaghan, and Mikkel Ostergaard: MRI in rheumatoid arthritis 5. Impact on life 20: Kathryn A. Gibson and Theodore Pincus: Patient physical function in rheumatoid arthritis 21: Emma Dures and Neil Basu: Fatigue 22: David L. Scott and Allan Wailoo: Health economics 23: Suzanne Verstappen, Cheryl Jones, Abdullah Houssien, and James Galloway: Rheumatoid arthritis and work 6. Non-drug treatments 24: Lindsay Bearne and Christina Opava: Exercise 25: Heidi Siddle and Anthony Redmond: Foot health 26: Alison Hammond, Joanne Adams, and Yeliz Prior: Occupational therapy 27: Marieke M.J.H. Voshaar: Self-management: a patient's perspective 7. Drug treatments 28: Mark D Russell and Nidhi Sofat: Analgesics, Opioids, and NSAIDs 29: Johannes W. G. Jacobs, Marlies C. van der Goes, Johannes W. J. Bijlsma, and Jose A. P. da Silva: Glucocorticoids 30: David L. Scott: Conventional disease modifying drugs 31: Peter Taylor and Nehal Narayan: Tumour necrosis factor inhibitors 32: Neelam Hassan and Ernest Choy: Interleukin-6 inhibitors 33: Yuzaiful Yusof, Edward Vital, and Maya Buch: B-cell therapies 34: Vibeke Strand, Jeffrey Kaine, and John Isaacs: Biosimilars 35: Meghna Jani, John Isaacs, and Vibeke Strand: Immunogenicity in response to biologic agents 36: Katie Bechman, James Galloway, and Peter Taylor: The use of JAK inhibitors in the treatment of rheumatoid arthritis 37: Ben G.T. Coumbe, Elena Nikiphorou, and Tuulikki Sokka-Isler: Combination therapy in rheumatoid arthritis 38: Jeremy Sokolove: Translation of new therapies: from bench to bedside 39: James Galloway and Mark Yates: Adverse events in clinical studies in rheumatoid arthritis 8. Management and outcomes 40: Tom W. J. Huizinga, Annette van der Helm-van Mil, and Andrew Cope: Prevention of rheumatoid arthritis 41: Kenneth F Baker and Arthur G Pratt: Treatment targets and remission 42: David L. Scott: Clinical outcomes 43: Anna-Birgitte Aga, Espen A. Haavardsholm, Till Uhlig, and Tore K. Kvien: Clinical guidelines 44: Angela Zink and Anja Strangfeld: European biologics registers 45: Jeff Greenberg and Sheetal Patel: Voluntary patient registries

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Medicina músculo-esquelética, motricidade
• Reumatologia
• Fisioterapia